PCMA Applauds Congressional Action on Legislation to Boost use of Biosimilars
April 15, 2021
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on legislation passed by Congress to...
Morning Consult: Congress Should Act Quickly to Permanently Repeal the Rebate Rule
April 12, 2021
While Congress and the Biden administration, as well as stakeholders across the prescription drug supply chain, examine policy options for...
Rebate Rule Effective Date Postponed to 2023
January 30, 2021
(Washington, D.C.) — In response to litigation brought by the Pharmaceutical Care Management Association (PCMA) challenging the Medicare Part D rebate...
PCMA Statement on Medicare Part D Premiums
July 29, 2020
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s announcement...
July 28, 2020
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of a TV and digital advertising campaign...
PCMA Statement on Administration’s Executive Order on Prescription Drug Pricing
July 24, 2020
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s...